Adalimumab for the Treatment of Patients With Moderately to Severely Active Psoriatic Arthritis: Results of a Double-Blind, Randomized, Placebo-Controlled Trial.
Mease, Philip J. MD 1; Gladman, Dafna D. MD, FRCPC 2; Ritchlin, Christopher T. MD 3; Ruderman, Eric M. MD 4; Steinfeld, Serge D. MD, PhD 5; Choy, Ernest H. S. MD, FRCP 6; Sharp, John T. MD 7; Ory, Peter A. MD 8; Perdok, Renee J. MS, MBA 9; Weinberg, Mark A. MD 9; Adalimumab Effectiveness in Psoriatic Arthritis Trial Study Group
Arthritis & Rheumatism.
52(10):3279-3289, October 2005.
(Format: HTML, PDF)